Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

NCT00794313 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Funding Ended

Conditions

Parkinson's Disease

Interventions

DRUG: Amantadine 300 mg
DRUG: Topiramate
DRUG: Sugar Pill

Sponsor

Oregon Health and Science University